Please assess the completion status of the following clinical trial:

Trial Title: A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who have had ulcerative colitis of at least 3 months' duration at screening~* Patients who have ulcerative colitis confirmed by the biopsy taken at screening~* Patients must have active colitis confirmed during the screening sigmoidoscopy~* Patients must have active disease.~Exclusion Criteria:~* Patients must not be likely to require surgical removal of all or part of the colon within 12 weeks of beginning the study~* Patients must not require, or required within the 2 months prior to beginning the study, surgery for active gastrointestinal bleeding, peritonitis, intestinal obstruction, or intra-abdominal or pancreatic abscess requiring surgical drainage

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).